Sunshine Website Goes Live With Some Context Sought By Industry
This article was originally published in The Pink Sheet Daily
Executive Summary
CMS releases data on $3.5 billion worth of payments made by drug and device companies to physicians and teaching hospitals in the last five months of 2013; an additional 199,000 payment records were not disclosed.
You may also be interested in...
Saudi FDA Wants Device & Drug Firms To Report Payments To Doctors, Health Institutions
The Saudi Food and Drug Authority has finalized the details of a new transparency initiative under which medical device and pharmaceutical companies will have to disclose their financial relationships with health-care professionals and institutions.
Saudi FDA Wants Drug & Device Firms To Report Payments To Doctors, Health Institutions
The Saudi Food and Drug Authority has finalized the details of a new transparency initiative under which drug and medical device companies will have to disclose their financial relationships with healthcare professionals and institutions.
GSK's Physician Communications Shifts To Internal Experts, Remote Formats
New global approach means that GlaxoSmithKline no longer will pay outside health care professionals to speak on firms' behalf.